Literature DB >> 2910586

Thermal inactivation of L-thyroxin.

J Wortsman1, D C Papadimitriou, M Borges, C L Defesche.   

Abstract

We assessed the extent of inactivation of L-thyroxin induced by exposure to heat in the presence of two vehicles. Preparations of L-thyroxin in the dry powder form, or dispersed in the solvents propylene glycol (water-like) or ethoxylated castor oil (oil-like), were heated at temperatures ranging from 65 to 160 degrees C, for 5- to 15-min periods. Heating L-thyroxin to a temperature below that of cooked bovine ground meat (72 degrees C) produced less than 10% degradation. Thermal degradation was pronounced only above 90 degrees C, and was almost completed at 160 degrees C. L-Triiodothyronine was the only thermal degradation product identified after L-thyroxin was heated at 125 degrees C. In a separate experiment we measured the melting point of L-thyroxin, 148.81 degrees C. This value agrees closely with the observed thermal sensitivity. We conclude that L-thyroxin is not significantly degraded under conditions encountered during cooking of ground bovine meat for short times at moderate temperatures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2910586

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Influence of formulation and processing factors on stability of levothyroxine sodium pentahydrate.

Authors:  Jarrod W Collier; Rakhi B Shah; Abhay Gupta; Vilayat Sayeed; Muhammad J Habib; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2010-05-08       Impact factor: 3.246

2.  Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium.

Authors:  Rakhi B Shah; Jarrod S Collier; Vilayat A Sayeed; Arthur Bryant; Muhammad J Habib; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2010-08-26       Impact factor: 3.246

3.  TSH-based protocol, tablet instability, and absorption effects on L-T4 bioequivalence.

Authors:  Marisa Eisenberg; Joseph J Distefano
Journal:  Thyroid       Date:  2009-02       Impact factor: 6.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.